Dyne Therapeutics, Inc.

DYN · Nasdaq · SIC 2834: Pharmaceutical Preparations
96
SEC Filings

Business Summary

Government regulationPatent term restoration and extension in this Annual Report on Form 10-K. In the future, if and when any product candidates we may develop receive FDA approval, we expect to apply for patent term extensions on issued patents covering those product candidates. Moreover, we intend to seek patent term adjustments and extensions for any of our issued patents in any jurisdiction where such adjustments and extensions are available. However, there is no guarantee that the applicabl...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionDYNdiscussed_in_filing Cybersecurity
topic_mentionDYNdiscussed_in_filing Cybersecurity
topic_mentionDYNdiscussed_in_filing Regulation
topic_mentionDYNdiscussed_in_filing Sovereign & Government
topic_mentionDYNdiscussed_in_filing Regulation
topic_mentionDYNdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001193125-26-084178EDGAR117K words
2025-02-272024-12-310000950170-25-028356EDGAR—
2024-03-052023-12-310000950170-24-025402EDGAR—
2023-03-022022-12-310000950170-23-005708EDGAR—
2022-03-102021-12-310000950170-22-003290EDGAR—
2021-03-042020-12-310001564590-21-010726EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266882EDGAR76K words
2025-07-282025-06-300000950170-25-099161EDGAR—
2025-05-082025-03-310000950170-25-066386EDGAR—
2024-11-122024-09-300000950170-24-124572EDGAR—
2024-08-122024-06-300000950170-24-095527EDGAR—
2024-05-022024-03-310000950170-24-052066EDGAR—
2023-10-302023-09-300000950170-23-056121EDGAR—
2023-08-032023-06-300000950170-23-037585EDGAR—
2023-05-112023-03-310000950170-23-020839EDGAR—
2022-11-032022-09-300000950170-22-021546EDGAR—
2022-08-042022-06-300000950170-22-014474EDGAR—
2022-05-022022-03-310000950170-22-006860EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-020001193125-26-084207EDGAR2K words
2026-01-120001193125-26-009782EDGAR—
2025-12-230001193125-25-329511EDGAR—
2025-12-100001193125-25-314249EDGAR—
2025-12-080001193125-25-311221EDGAR—
2025-12-080001193125-25-310516EDGAR—
2025-11-050001193125-25-266979EDGAR—
2025-10-020001193125-25-228317EDGAR—
2025-08-040000950170-25-101620EDGAR—
2025-07-280000950170-25-099184EDGAR—

96 total filings indexed. 68 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001818794
TickerDYN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d4d1ed7ef130840e5df3aeb60f11142839aaabb6327c1ca850fd41ecc57e9bc0
parent: 696ac07efa2c774349d7f516450eda3828c0cdbae80559a765610aba3fdc0589
content hash: 238cec565b87328ba46a1bbad01e5520a647d23171f7d2095c18aa8f7c7bc640
signed: 2026-04-13T04:44:45.437Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf